US FDA Emphasizes Timesavers In New eCopy Guidance
This article was originally published in Clinica
The US FDA's device center wants PDFs submitted through the system to be formatted properly to prevent unnecessary delays when reviewers work with them. With this aim in mind, on Dec. 3, the Center for Devices and Radiological Health released an updated guidance (PDF) for industry on its electronic copy (eCopy) program for medical device submissions based on recommendations from Booz Allen Hamilton as part of the contractor's ongoing independent review of FDA's procedures.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.